ArticleJournal of clinical medicine2022

Impact of KRAS Mutation Subtypes and Co-Occurring Mutations on Response and Outcome in Advanced NSCLC Patients following First-Line Treatment.

Yingjia Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.